Society guideline links: Invasive fungal infections

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Candidiasis" and "Society guideline links: Aspergillosis" and "Society guideline links: Pneumocystis pneumonia in patients without HIV".)

International

●International Society for Heart and Lung Transplantation (ISHLT): Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients – Executive summary, 2015 (published 2016)

Canada

●Canadian Paediatric Society (CPS): Practice point on antifungal agents for common outpatient paediatric infections (2019)

United States

●Centers for Disease Control and Prevention (CDC): Fungal diseases – Resources for health care providers

●American Society of Transplantation (AST): Guidelines on emerging fungal infections in solid organ transplant recipients (2019)

●American Thoracic Society (ATS): An official clinical practice guideline on microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice (2019)

●AST: Guidelines on donor-derived fungal infections in organ transplant recipients (2012)

●ATS: An official statement for treatment of fungal infections in adult pulmonary and critical care patients (2011)

Europe

●European Conference on Infections in Leukaemia (ECIL): Guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation, 2020 (published 2021)

●ECIL: Recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients (2012)

Australia–New Zealand

●Australasian Antifungal Guidelines Steering Committee: Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation (2021)

●Australasian Antifungal Guidelines Steering Committee: Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting (2021)

●Australasian Antifungal Guidelines Steering Committee: Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients (2021)

●Australasian Antifungal Guidelines Steering Committee: Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting (2021)